Heartseed株式会社 · Pharmaceutical · FY ends Oct
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Keiichi Fukuda | 3,146,000 | 13.76% | ¥5.8B | — |
| 2 | SBI Ventures Two | 2,236,800 | 9.79% | ¥4.1B | — |
| 3 | Toshiharu Furukawa | 920,000 | 4.02% | ¥1.7B | — |
| 4 | Kenzo Shinmura | 842,400 | 3.69% | ¥1.6B | — |
| 5 | Innovation Planning 21 | 650,000 | 2.84% | ¥1.2B | — |
| 6 | JMDC | 461,600 | 2.02% | ¥850M | — |
| 7 | 秋山 琢己 | 441,000 | 1.93% | ¥812M | — |
| 8 | Daisuke Gomi | 350,000 | 1.53% | ¥644M | — |
| 9 | SBI AI&Blockchain投資事業有限責任組合 | 264,700 | 1.16% | ¥487M | — |
| 10 | Medpal Holdings | 250,000 | 1.09% | ¥460M | — |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Keiichi Fukuda | President & Representative Director | 3,146,000 | ¥5.8B | — |
| 安井 季久央 | Director, COO | 35,200 | ¥64.8M | — |
| 金子 健彦 | Director, CMO | — | — | — |
| 高野 六月 | Director, CFO | 50,400 | ¥92.8M | — |
| 平野 達義 | Director | 2,400 | ¥4.4M | — |
| 河西 佑太郎 | Director | — | — | — |
| Toshiharu Furukawa | Director | 920,000 | ¥1.7B | — |
| 出口 恭子 | Director | 18,400 | ¥33.9M | — |
| 菊川 知之 | Audit & Supervisory Board Member | 21,600 | ¥39.8M | — |
| 藤吉 彰 | Audit & Supervisory Board Member | 18,400 | ¥33.9M | — |
| 江戸川 泰路 | Audit & Supervisory Board Member | 5,600 | ¥10.3M | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Dec 2025 | ¥1,841 | ¥8.44 | 218.1x | — | 22,858,200 |
| FY ending Oct 2024 | — | ¥-49.43 | — | — | 22,225,400 |